Patient view on COVID-19: Shielding and interactions with other lung diseases

Susannah Lindey, S. Schiza (Heraklion, Greece)

Source: ERS Course 2021 - COVID-19: State of the art
Number: 14

Webcast

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Susannah Lindey, S. Schiza (Heraklion, Greece). Patient view on COVID-19: Shielding and interactions with other lung diseases. ERS Course 2021 - COVID-19: State of the art

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Study of sexuality in patients with lung diseases: ²need to bridge psycosocial barriers in patient rehabilitation²
Source: Eur Respir J 2006; 28: Suppl. 50, 371s
Year: 2006

Non Specific Interstitial Pneumonia and features of connective tissue disease:what are the consequences of a different point of view?
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis:  mechanistic insights and prognostic markers
Year: 2018


Smoking-related lung diseases: a clinical perspective
Source: Eur Respir J 2010; 35: 231-233
Year: 2010


Late Breaking Abstract - ‘Shielding’: Patient experience of measures to reduce risk of COVID-19 in those with pre-existing respiratory conditions
Source: Virtual Congress 2020 – Optimising the benefits of pulmonary rehabilitation
Year: 2020


Rare lung diseases and work: always bear occupation in mind when assessing these patients
Source: Virtual Congress 2020 – How much lung disease is really caused by work, and how to assess the worker who wishes to continue working?
Year: 2020


Challenges to travelling with a lung condition: a patient perspective
Source: International Congress 2017 – Air travel for respiratory patients
Year: 2017


Lung transplantation: the patient view from either side of the operating table
Source: Breathe, 17 (1) 200305; 10.1183/20734735.0305-2020
Year: 2021



The future of treatment for interstitial lung diseases: the patient’s and physician’s perspective
Source: International Congress 2019 – Rare lung diseases
Year: 2019


General practitioners and rare lung diseases: a task force for the development of rare lung diseases educational material
Source: Breathe 2016; 12: 341-348
Year: 2016


General practitioners and rare lung diseases: a task force for the development of rare lung diseases educational material
Source: Guideline 2017
Year: 2016

Patient view of COPD and its influence upon compliance
Source: Eur Respir J 2003; 22: Suppl. 45, 424s
Year: 2003

Interims analysis of the EXCITING-ILD registry (registry for exploring clinical and epidemiological characteristics of interstitial lung diseases)
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016